$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Does fostatinib cause weight gain?
2026-02-01 22:25:32
Check Details
Analysis of side effects of dabrafenib/dabrafenib: What should patients pay attention to when taking the drug?
2026-02-01 22:25:32
Check Details
Can cabozantinib be reimbursed by medical insurance? Financial Burden and Solutions for Patients’ Medication
2026-02-01 22:25:32
Check Details
None
2026-02-01 22:25:32
Check Details
Eltrombopag/eltrombopag in the treatment of aplastic anemia: How long does it take to be effective?
2026-02-01 22:25:32
Check Details
An in-depth analysis of the clinical value of the innovative platelet-generating drugs Ropremilast/Romigrastim
2026-02-01 22:25:32
Check Details
Detailed instructions for the anticancer drug midostaurin: indications, usage, dosage and precautions
2026-02-01 22:25:32
Check Details
Analysis of the side effects of the milk-reducing drug cabergoline: What issues should breastfeeding women pay attention to?
2026-02-01 22:25:32
Check Details
Analysis of the marketing status of molotinib/mometinib in China: key information patients need to know
2026-02-01 22:25:32
Check Details
A must-read for HIV-infected people: Scientific response strategies for missing doses of Bituvi/Bikernoprenol tablets for 24 hours
2026-02-01 22:25:32
Check Details
Detailed explanation of the indications of trametinib: Which patients can benefit from this targeted drug?
2026-02-01 22:25:32
Check Details
Is dabrafenib/dabrafenib a targeted drug? Revealing its anti-cancer mechanism and clinical application
2026-02-01 22:25:32
Check Details
1
2
...
1325
1326
1327
1328
1329
1330
1331
...
10239
10240
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Ribociclib: Mechanism of Action and Approved Uses in Breast Cancer
2
Revumenib: Key Considerations Before and During Treatment
3
Pacritinib in Myelofibrosis: Evidence on Spleen Volume Reduction and Symptom Control
4
Binimetinib + Encorafenib: Dual MEK/BRAF Targeting in BRAF+ Tumors
5
Neratinib Dosing: 240mg Start, Diarrhea Prophylaxis, Hepatic Adjustment
6
Pomalidomide vs Thalidomide: IMiD Generation Gap and MM Use
7
Dasatinib: A BCR-ABL Targeted TKI, Not Conventional Chemo
8
Obeticholic Acid (OCA): FXR Therapy in PBC and Liver Safety Limits
9
Selumetinib and KRAS Mutations: Where the MEK Inhibitor Actually Fits
10
Erdafitinib in Lung Squamous Cell Carcinoma: Indication Boundaries and FGFR Interpretation
11
Eltrombopag: TPO-Receptor Agonist in ITP and Severe Aplastic Anemia
12
Ganaxolone for CDKL5-Related Seizures: GABA-A Modulation, Not a Cure